EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

K M Jordan, N K Arden, M Doherty, B Bannwarth, J W J Bijlsma, P Dieppe, K Gunther, H Hauselmann, G Herrero-Beaumont, P Kaklamanis, S Lohmander, B Leeb, M Lequesne, B Mazieres, E Martin-Mola, K Pavelka, A Pendleton, L Punzi, U Serni, B Swoboda, G Verbruggen, I Zimmerman-Gorska, M Dougados, Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT, K M Jordan, N K Arden, M Doherty, B Bannwarth, J W J Bijlsma, P Dieppe, K Gunther, H Hauselmann, G Herrero-Beaumont, P Kaklamanis, S Lohmander, B Leeb, M Lequesne, B Mazieres, E Martin-Mola, K Pavelka, A Pendleton, L Punzi, U Serni, B Swoboda, G Verbruggen, I Zimmerman-Gorska, M Dougados, Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT

Abstract

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach.

Methods: The literature search and guidelines were restricted to treatments for knee OA pertaining to clinical and/or radiological OA of any compartment of the knee. Papers for combined treatment of knee and other types of OA were excluded. Medline and Embase were searched using a combination of subject headings and key words. Searches for those treatments previously investigated were conducted for January 1999 to February 2002 and for those treatments not previously investigated for 1966 to February 2002. The level of evidence found for each treatment was documented. Quality scores were determined for each paper, an effect size comparing the treatment with placebo was calculated, where possible, and a toxicity profile was determined for each treatment modality.

Results: 497 new publications were identified by the search. Of these, 103 were intervention trials and included in the overall analysis, and 33 treatment modalities were identified. Previously identified publications which were not exclusively knee OA in the initial analysis were rejected. In total, 545 publications were included. Based on the results of the literature search and expert opinion, 10 recommendations for the treatment of knee OA were devised using a five stage Delphi technique. Based on expert opinion, a further set of 10 items was identified by a five stage Delphi technique as important for future research.

Conclusion: The updated recommendations support some of the previous propositions published in 2000 but also include modified statements and new propositions. Although a large number of treatment options for knee OA exist, the evidence based format of the EULAR Recommendations continues to identify key clinical questions that currently are unanswered.

Figures

Figure 1
Figure 1
Toxicity profile of the treatment modalities based on expert opinion (23 experts).

References

    1. Rheumatology (Oxford). 1999 Jul;38(7):602-7
    1. Clin Ther. 1999 Sep;21(9):1549-62
    1. Osteoarthritis Cartilage. 1994 Mar;2(1):61-9
    1. Arch Intern Med. 2001 Oct 22;161(19):2309-16
    1. J Strength Cond Res. 2001 Aug;15(3):337-40
    1. JAMA. 2002 Jan 2;287(1):64-71
    1. Ann Rheum Dis. 2002 Jan;61(1):24-8
    1. Osteoarthritis Cartilage. 2001 Nov;9(8):738-45
    1. Arthritis Rheum. 2002 Nov;46(11):2831-5
    1. Clin Evid. 2002 Dec;(8):1212-37
    1. Arthritis Care Res. 1999 Apr;12(2):101-11
    1. Arch Phys Med Rehabil. 1999 Oct;80(10):1293-9
    1. Osteoarthritis Cartilage. 2001 Apr;9(3):273-80
    1. J Rheumatol. 2001 May;28(5):1073-6
    1. J Rheumatol. 2001 Jul;28(7):1655-65
    1. Rheumatol Rehabil. 1980 Nov;19(4):212-7
    1. Curr Med Res Opin. 1982;8(3):145-9
    1. Clin Orthop Relat Res. 1987 Aug;(221):181-7
    1. Arthritis Rheum. 1989 Dec;32(12):1577-83
    1. Int Orthop. 1991;15(1):31-3
    1. Clin Ther. 1991 May-Jun;13(3):383-95
    1. Ann Intern Med. 1992 Apr 1;116(7):535-9
    1. J Rheumatol. 1992 Dec;19(12):1950-4
    1. Arthritis Rheum. 1993 Sep;36(9):1196-206
    1. J R Coll Physicians Lond. 1993 Oct;27(4):391-6
    1. Am J Public Health. 1994 Mar;84(3):351-8
    1. Ann Rheum Dis. 1995 May;54(5):379-81
    1. BMJ. 1995 Jul 1;311(6996):22-6
    1. Brain Res. 1995 Sep 18;692(1-2):47-56
    1. BMJ. 1996 Apr 13;312(7036):940-3
    1. J Arthroplasty. 1996 Jan;11(1):34-46
    1. Ann Rheum Dis. 1996 Jul;55(7):424-31
    1. J Rheumatol. 1996 Aug;23(8):1385-91
    1. J Rheumatol. 1996 Sep;23(9):1579-85
    1. Osteoarthritis Cartilage. 1993 Apr;1(2):97-103
    1. Ann Rheum Dis. 1996 Nov;55(11):829-32
    1. Arthritis Care Res. 1996 Aug;9(4):292-301
    1. Osteoarthritis Cartilage. 1997 May;5(3):153-60
    1. Mayo Clin Proc. 1999 Nov;74(11):1095-105
    1. J Rheumatol. 1999 Dec;26(12):2659-63
    1. Ann Intern Med. 2000 Feb 1;132(3):173-81
    1. West J Med. 2000 Feb;172(2):91-4
    1. JAMA. 2000 Mar 15;283(11):1469-75
    1. Arthritis Rheum. 2000 May;43(5):995-1000
    1. Clin Orthop Relat Res. 2000 Jun;(375):185-92
    1. Osteoarthritis Cartilage. 2000 Sep;8(5):343-50
    1. J Am Geriatr Soc. 2000 Sep;48(9):1062-72
    1. J Rheumatol. 2000 Sep;27(9):2215-21
    1. Arthritis Rheum. 2000 Oct;43(10):2339-48
    1. Ann Rheum Dis. 2000 Dec;59(12):936-44
    1. J Rheumatol. 2001 Jan;28(1):156-64
    1. J Rheumatol. 2001 Jan;28(1):173-81
    1. Ann Rheum Dis. 2001 Feb;60(2):91-7
    1. Lancet. 2001 Jan 27;357(9252):251-6
    1. Scand J Rheumatol. 2001;30(1):11-8
    1. Arthritis Rheum. 1997 Aug;40(8):1466-74
    1. Scand J Rheumatol. 1997;26(4):287-92
    1. J Med Assoc Thai. 1997 Sep;80(9):593-7
    1. J Epidemiol Community Health. 1998 Jun;52(6):377-84
    1. Arthritis Rheum. 1999 Mar;42(3):475-82
    1. J Gerontol A Biol Sci Med Sci. 1999 Apr;54(4):M184-90
    1. J Bone Joint Surg Am. 1999 Apr;81(4):539-48
    1. Rheumatology (Oxford). 1999 Jan;38(1):73-83
    1. Ann Rheum Dis. 1999 Jan;58(1):15-9
    1. Arthritis Rheum. 1999 Jun;42(6):1267-73
    1. Arthritis Rheum. 1999 Jul;42(7):1370-7

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe